InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,762.48
(
0.42%
)
US TECH 100
19,499.20
(
0.15%
)
Dow Jones
42,330.15
(
0.04%
)
Brent Oil
71.76
(
-0.32%
)
Bitcoin
63,308.50
(
-0.03%
)
Post# of 20689
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120519
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Bio_pete post# 9107

Thursday, 06/14/2012 10:22:22 AM

Thursday, June 14, 2012 10:22:22 AM

Post# of 20689

Will TEVA be able to extend the patent protection for Copaxone with this newer formulation?

Teva should be able to get patent protection for the new thrice-weekly 40mg formulation, but this has no effect on the Copaxone patents being litigated between Teva, NVS/MNTA, and MYL, all of which pertain to regular Copaxone (which is dosed 20mg daily).

As noted in #msg-72989576, the thrice-weekly 40mg formulation of Copaxone will be a distinct branded drug and will not be substitutable for a prescription written for regular Copaxone.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

BARRON'S COVE to Premier at the Hamptons International Film Festival • APHP • Sep 30, 2024 2:56 PM

Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM

Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM

North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM

CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM

Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM

Start posting your company's news
Only $200 per official company press release!